CAPTRUST Financial Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8	Closed	–	–	5182
2022 Q1	$0	Buy	+8	New	–	﹤0.01%	5181